Solute Carrier Family 34 (Type II Sodium/phosphate Contransporter), Member 1 抗体

Martins, Liu, Sneddon, Friedman, Demay: "1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice." in: Endocrinology, Vol. 160, Issue 10, pp. 2204-2214, (2019) (PubMed).

Ide, Ye, Courbebaisse, Olauson, Densmore, Larsson, Hanai, Lanske: "In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules." in: American journal of physiology. Renal physiology, Vol. 315, Issue 5, pp. F1261-F1270, (2018) (PubMed).

Mace, Gravesen, Nordholm, Hofman-Bang, Secher, Olgaard, Lewin: "Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia." in: Kidney international, (2017) (PubMed).

Suzuki, Seki, Hiramoto, Naganuma, Kobayashi, Yamaoka, Baird, Takahashi, Sato, Yamamoto: "Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus." in: Nature communications, Vol. 8, pp. 14577, (2017) (PubMed).

Liu, Martins, Raimann, Chae, Brooks, Jorgetti, Bouxsein, Demay: "1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression." in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 31, Issue 5, pp. 929-39, (2016) (PubMed).

Robijn, Vervaet, DHaese, Verhulst: "Evaluation of intestinal phosphate binding to improve the safety profile of oral sodium phosphate bowel cleansing." in: PLoS ONE, Vol. 10, Issue 3, pp. e0116590, (2015) (PubMed).